COHEN RAYMOND W — SEC insider filings
SEC reporting owner CIK 1258288. 27 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2020-08-11 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 27,000 shares, $488,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 35 legs across 16 filings — 511,456 shares, $30,171,048 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 50,000 shares @ $77.11 ($3,855,350) in Axonics, Inc., filed 2021-09-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Axonics, Inc. (AXNX) | Chief Executive Officer, Director | 16 | — | 33 legs · 502,501 sh · $29,891,012 | 30 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Director | 5 | 2 legs · 27,000 sh · $488,800 | 1 leg · 3,330 sh · $97,504 | 3 |
| BIOLIFE SOLUTIONS INC (BLFS) | Director | 3 | — | 1 leg · 5,625 sh · $182,531 | 2 |
| RxSight, Inc. (RXST) | Director | 2 | — | — | 2 |
| InspireMD, Inc. (NSPR) | Director | 1 | — | — | 1 |
Insider filings — COHEN RAYMOND W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Sale (S): 3,330 @ $29.28 | EDGAR |
| 2026-09-10 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Grant/award (A): 7,217 | EDGAR |
| 2026-06-18 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 30,864 | EDGAR |
| 2026-03-30 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Purchase (P): 10,000 @ $19.98 | EDGAR |
| 2026-01-16 | 4 | InspireMD, Inc. (NSPR) | Grant/award (A): 44,030 @ $0 | EDGAR |
| 2025-09-08 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Purchase (P): 17,000 @ $17 · Grant/award (A): 10,909 | EDGAR |
| 2025-08-04 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 35,668 @ $0 | EDGAR |
| 2025-07-24 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Grant/award (A): 12,994 | EDGAR |
| 2024-11-15 | 4 | Axonics, Inc. (AXNX) | Disposition to issuer (D): 292,731 @ $71 · Disposition to issuer (D): 31,125 (derivative) @ $0 · Disposition to issuer (D): 196,451 (derivative) @ $56.81 · Disposition to issuer (D): 106,776 (derivative) @ $69.37 | EDGAR |
| 2024-07-25 | 4 | Axonics, Inc. (AXNX) | Option exercise (M): 25,771 @ $14.19 · Option exercise (M): 78,125 @ $25.82 · Option exercise (M): 78,125 (derivative) @ $0 · Option exercise (M): 25,771 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Axonics, Inc. (AXNX) | Option exercise (M): 63,400 @ $0 · Sale (S): 35,161 @ $67.74 · Option exercise (M): 21,900 (derivative) @ $0 · Option exercise (M): 41,500 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Axonics, Inc. (AXNX) | Grant/award (A): 20,750 @ $0 · Option exercise (M): 61,968 @ $0 · Sale (S): 13,872 @ $61.17 · Sale (S): 9,032 @ $61.12 · Sale (S): 1,185 @ $60.43 · Sale (S): 6,932 @ $61.02 · +4 more | EDGAR |
| 2023-01-18 | 4 | Axonics, Inc. (AXNX) | Sale (S): 18,684 @ $65.54 · Sale (S): 22,052 @ $66.27 | EDGAR |
| 2022-08-10 | 4 | Axonics, Inc. (AXNX) | Sale (S): 18,100 @ $69.50 · Sale (S): 12,092 @ $70.40 · Sale (S): 12,032 @ $71.65 · Sale (S): 1,776 @ $72.09 | EDGAR |
| 2022-03-31 | 4 | Axonics, Inc. (AXNX) | Sale (S): 50,000 @ $60 | EDGAR |
| 2022-03-16 | 4 | Axonics, Inc. (AXNX) | Sale (S): 17,787 @ $50.42 · Sale (S): 2,100 @ $51.40 · Sale (S): 1,981 @ $52.66 · Sale (S): 11,232 @ $53.95 · Sale (S): 16,900 @ $54.80 | EDGAR |
| 2022-02-03 | 4 | Axonics, Inc. (AXNX) | Grant/award (A): 43,297 @ $0 · Option exercise (M): 96,846 @ $0 · Sale (S): 33,336 @ $48.21 · Sale (S): 1,779 @ $49.03 · Grant/award (A): 21,968 (derivative) @ $0 · Grant/award (A): 10,950 (derivative) @ $0 · +2 more | EDGAR |
| 2021-09-13 | 4 | Axonics, Inc. (AXNX) | Sale (S): 50,000 @ $77.11 | EDGAR |
| 2021-07-14 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/award (A): 5,000 | EDGAR |
| 2021-06-10 | 4 | Axonics, Inc. (AXNX) | Sale (S): 33,333 @ $60 | EDGAR |
| 2021-05-20 | 4 | Axonics, Inc. (AXNX) | Sale (S): 32,833 @ $55 | EDGAR |
| 2021-05-12 | 4 | Axonics, Inc. (AXNX) | Sale (S): 13,109 @ $52.98 · Sale (S): 17,954 @ $54.13 · Sale (S): 2,770 @ $54.81 | EDGAR |
| 2021-02-02 | 4 | Axonics Modulation Technologies, Inc. (AXNX) | Grant/award (A): 20,000 @ $0 · Option exercise (M): 33,334 @ $0 · Sale (S): 12,675 @ $51.36 · Sale (S): 952 @ $52.12 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 42,500 (derivative) @ $0 · +1 more | EDGAR |
| 2021-01-27 | 4 | Axonics Modulation Technologies, Inc. (AXNX) | Option exercise (M): 27,173 @ $0 · Sale (S): 7,842 @ $53.58 · Option exercise (M): 27,173 (derivative) @ $0 | EDGAR |
| 2020-11-16 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Sale (S): 5,625 @ $32.45 | EDGAR |
| 2020-10-07 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/award (A): 5,000 | EDGAR |
| 2020-08-11 | 4 | Axonics Modulation Technologies, Inc. (AXNX) | Sale (S): 16,633 @ $41.82 · Sale (S): 3,367 @ $42.75 · Sale (S): 5,159 @ $40.95 · Sale (S): 8,808 @ $42.05 · Sale (S): 11,033 @ $42.78 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1258288 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs